TheStreet: Stock Quotes, Financial Market News, & Investment Advice

Commentary

China Stocks for the Holidays

Yongye, New Energy Systems, China Biotics and Jade Art are four for your shopping list.

Vote in our Poll

Will the Dreamliner Revolutionize Airlines?

Is the birth of the Dreamliner the answer to the airline industry's woes?

Most Commented Story Today

Gold: Is Your Money Better Off in the Bank?

As gold prices continue to fall, TheStreet calculates that you're likely better off putting your money in a savings account.

Videos

Stock Wrap: The Real Story, December 21

Stocks surged Monday, buoyed by blue-chip upgrades, deal news and the health care sector.

Videos

Gold's Tug of War

NEW YORK (TheStreet) - Jon Nadler, senior analyst at Kitco.com, says speculating is the name of the gold game this week as the precious metal resumes its tug of war with the U.S. dollar and bargain hunters.

Videos

Healthy Drug Deals

NEW YORK (TheStreet) - - Pfizer's licensing deal and Sanofi's acquisition of Chattem are just what the investment doctor ordered.

Stanley Bing

Big Business Can Play Santa

Citigroup's announcement to suspend foreclosures and evictions for 30 days for 4,000 borrrowers is a nice idea that should be replicated by other businesses.

Best in Class Business

Umpqua Gets Creative: Best in Class

While many community banks are still struggling with fallout from the housing sector, Umpqua is using unconventional methods to build its deposit base.

Between the Lines
Dave's Daily
Dave's Daily: Here Comes Santa Claus

M&A announcements from Sanofi-Aventis, Bucyrus and Spyker cheered investors. Volume was super light which is typical for a holiday week, while breadth was positive.

Banks & Insurers
The Greatest of All-Time: Buffett Leads Poll

Warren Buffett can add one more accolade to his Omaha fireplace mantle: a new poll shows Buffett placing No. 1 all-time among players in the investment and business world.

Technology
Take-Two Cuts Guidance Again

The game maker sells its distribution business and takes another hit on profit.

Biotech
OncoGenex Slammed on Teva Partnership: BioBuzz

Licensing deal for prostate cancer drug disappoints investors, sending OncoGenex shares sharply lower.

ETFs
Health Care Plan Poses Risks for ETFs

The latest health care proposal could smother recent gains seen by medical devices and pharmaceutical ETFs.

Earnings
Walgreen's Holiday Sales Drag

Walgreen posts a 20% jump in quarterly profit, helped by prescription drugs and flu shots. But the drugstore is seeing weakness in December.

IPOs
Poll Swings and Misses on IPOs

In a disappointing week for IPOs, TheStreet users miss the mark in attempting to peg the most successful deal.

Mergers & Acquisitions
Chesapeake No. 1 Energy Target, Poll Says

Looking to handicap the energy sector M&A race after Exxon-XTO? Chesapeake Energy is the No. 1 target for an energy sector takeover, according to a new poll from TheStreet users.

TheStreet Ratings
Fidelity's 10 Best-Performing Mutual Funds

Gold, materials and pharmaceuticals stocks powered Fidelity Investments' mutual funds.

Winners & Losers
'Fast Money' Recap: Retail Rally

The trading panel discusses the retail rally after the weekend's snow storm.

Try RealMoney Free Trial Now
Who is Bullish on RealMoney Today See all RealMoney Gurus

Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,414.14 1,114.05 2,237.66 36.82
Oil *
72.73
UP
85.25
UP
11.58
UP
25.97
UP
1.36
10 Yr
3.68%
SPDR Gold
106.95
+0.83%
+1.05%
+1.17%
+3.84%
Data delayed 20 minutes

More From TheStreet

Latest Headlines

Brokerage Partners

TheStreet Premium Services

All Services

Special Advertising Features